Xie He-Hui, Zhang Xiao-Fei, Chen Yuan-Yuan, Shen Fu-Ming, Su Ding-Feng
Department of Pharmacology, Second Military Medical University, Shanghai, P.R.China.
Hypertens Res. 2008 Apr;31(4):685-91. doi: 10.1291/hypres.31.685.
This study was designed to investigate the effects of a hydrochlorothiazide-nifedipine combination on blood pressure (BP), blood pressure variability (BPV), baroreflex sensitivity (BRS), and organ protection in spontaneously hypertensive rats (SHR). The doses used were 10 mg/kg/d for both hydrochlorothiazide and nifedipine, and 10+10 mg/kg/d for the combination of these two drugs. Drugs were mixed into rat chow at the aforementioned doses. SHR were treated for 4 months, and then BP was continuously recorded for 24 h. After the determination of BRS, rats were killed for organ-damage evaluation. It was found that long-term treatment with hydrochlorothiazide, nifedipine or both significantly decreased BP and BPV, enhanced BRS and conferred organ protection in SHR. The combination of hydrochlorothiazide and nifedipine had a significant synergistic effect on BPV reduction, BRS enhancement and organ protection in SHR, whereas no obvious synergism on BP reduction was found. Multiple-regression analysis showed that the decrease in left ventricular and aortic hypertrophy was most closely associated with the decrease in systolic BPV and the increase in BRS, and the amelioration of renal lesions was most closely associated with the increase in BRS. In conclusion, long-term treatment with a combination of hydrochlorothiazide and nifedipine yielded a significantly synergistic effect on BPV reduction, BRS restoration and organ protection in SHR. In addition to BP reduction, the decrease in BPV and the enhancement of BRS may have made important contributions to the observed organ protection.
本研究旨在探讨氢氯噻嗪 - 硝苯地平联合用药对自发性高血压大鼠(SHR)血压(BP)、血压变异性(BPV)、压力反射敏感性(BRS)及器官保护作用的影响。氢氯噻嗪和硝苯地平的用药剂量均为10 mg/kg/d,二者联合用药剂量为10 + 10 mg/kg/d。将药物按上述剂量混入大鼠饲料中。对SHR进行4个月的治疗,然后连续记录24小时血压。测定BRS后,处死大鼠进行器官损伤评估。结果发现,长期使用氢氯噻嗪、硝苯地平或二者联合用药均可显著降低SHR的血压和BPV,增强BRS并对其器官起到保护作用。氢氯噻嗪与硝苯地平联合用药在降低SHR的BPV、增强BRS及器官保护方面具有显著的协同作用,而在降低血压方面未发现明显协同作用。多元回归分析表明,左心室和主动脉肥厚的减轻与收缩期BPV的降低及BRS的增加最为密切相关,肾损伤的改善与BRS的增加最为密切相关。总之,氢氯噻嗪与硝苯地平联合长期治疗对降低SHR的BPV、恢复BRS及器官保护具有显著的协同作用。除降低血压外,BPV的降低和BRS的增强可能对观察到的器官保护起到了重要作用。